Published in Clin Chim Acta on May 15, 1992
Ability of whole blood aggregometer to detect platelet hyperaggregability. Am J Clin Pathol (1989) 3.30
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg (2000) 2.27
Importance of dural ectasia in phenotypic assessment of Marfan's syndrome. Lancet (1999) 2.20
Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med (2010) 2.04
Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res (2001) 1.92
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost (2007) 1.91
Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the 'Florence' diet is not Mediterranean. Eur J Clin Nutr (2005) 1.85
Improving healthcare worker hand hygiene adherence before patient contact: a before-and-after five-unit multimodal intervention in Tuscany. Qual Saf Health Care (2009) 1.68
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol (1999) 1.68
Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg (2001) 1.59
Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur Heart J (2000) 1.53
Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials. Diabetes Obes Metab (2008) 1.46
Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost (1997) 1.45
[Is evidence-based medicine really a craze? Surely it is fashionable to criticize it. A methodologic comment from the Centro Italiano per la Medicina Basata sulle Prove (Italian Center for Proof-Based Medicine)]. Ital Heart J Suppl (2000) 1.45
Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation (1996) 1.45
Silent ischemia in unstable angina is related to an altered cardiac norepinephrine handling. Circulation (1993) 1.44
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels. Thromb Haemost (1999) 1.42
Early out-of-hospital lidocaine administration decreases the incidence of primary ventricular fibrillation in acute myocardial infarction. J Emerg Med (1994) 1.41
The role of cysteine and homocysteine in venous and arterial thrombotic disease. Am J Clin Pathol (2001) 1.38
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res (2001) 1.26
Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis. Pharmacogenomics J (2010) 1.25
Acute T-cell activation is detectable in unstable angina. Circulation (1997) 1.19
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res (1999) 1.08
Physiologic role of coronary PGI2 and PGE2 in modulating coronary vascular response to sympathetic stimulation. Am Heart J (1990) 1.02
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost (1998) 1.02
Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. Atherosclerosis (2006) 0.99
Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet (1998) 0.99
Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res (1998) 0.96
Aspirin effect on early and late changes in acute lung injury in sheep. Intensive Care Med (1993) 0.96
Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res (1998) 0.95
Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients. J Thromb Haemost (2009) 0.95
ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2005) 0.94
The value of lung ultrasound monitoring in H1N1 acute respiratory distress syndrome. Anaesthesia (2009) 0.94
Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy. Am J Physiol Heart Circ Physiol (2000) 0.93
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost (1998) 0.93
Early Lactococcus lactis endocarditis after mitral valve repair: a case report and literature review. Infection (2012) 0.93
Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: relationships to coronary pathoanatomy, risk factors, and clinical manifestations. Am Heart J (1981) 0.92
Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins Leukot Essent Fatty Acids (1990) 0.92
Reduced prostacyclin production in patients with different manifestations of ischemic heart disease. Am J Cardiol (1982) 0.92
Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation? Cardiovasc Res (1981) 0.92
Partial anomalous venous return associated with intact atrial septum and persistent left superior vena cava: a case report and literature review. Cardiologia (1999) 0.92
Anomalous origin of the circumflex artery and patent foramen ovale: a rare cause of myocardial ischaemia after percutaneous closure of the defect. Heart (2003) 0.91
Leisure time but not occupational physical activity significantly affects cardiovascular risk factors in an adult population. Eur J Clin Invest (2007) 0.91
Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlation. Clin Genet (2001) 0.91
Age-related changes in the hemostatic system. Int J Clin Lab Res (1993) 0.91
Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J (2001) 0.91
Reduction in deep vein thrombosis incidence in intensive care after a clinician education program. J Thromb Haemost (2009) 0.90
Influence of eNOS gene polymorphisms on carotid atherosclerosis. Eur J Vasc Endovasc Surg (2004) 0.90
Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty. Pacing Clin Electrophysiol (1996) 0.89
World distribution of the T833C/844INS68 CBS in cis double mutation: a reliable anthropological marker. Hum Genet (1999) 0.88
Platelet activation and platelet lipid composition in pulmonary cancer. Prostaglandins Leukot Essent Fatty Acids (1995) 0.88
Renal endothelin in heart failure and its relation to sodium excretion. Am Heart J (2000) 0.88
Defective coronary prostaglandin modulation in anginal patients. Am Heart J (1990) 0.88
Extracorporeal membrane oxygenation in brain-death organ and tissues donors: a single-centre experience. Br J Anaesth (2013) 0.88
The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis (2008) 0.87
Protein Z plasma levels in different phases of activity of coronary atherosclerosis. J Thromb Haemost (2005) 0.87
Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives. J Thromb Haemost (2004) 0.86
Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet (1990) 0.86
Kinetic analysis of a TxA2 receptor antagonist. Evidence for the existence of an uptake system. Eicosanoids (1990) 0.86
Activity of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study. Pharmacol Res (1989) 0.86
The Stroke in Italy and Related Impact on Outcome (SIRIO) study: design and baseline data. Neurol Sci (2006) 0.86
Changes in blood pressure reactivity and 24-hour blood pressure profile occurring at puberty. Angiology (1994) 0.86
Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 Study. Thromb Haemost (2013) 0.85
Atrioventricular interval optimization in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements. Pacing Clin Electrophysiol (2000) 0.85
Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis (2002) 0.85
Collateral circulation in internal carotid artery occlusion. A study by duplex scan and magnetic resonance angiography. Minerva Cardioangiol (2002) 0.85
Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: a dietary intervention study. Nutr Metab Cardiovasc Dis (2009) 0.85
Detection of apical hypertrophic cardiomyopathy by magnetic resonance imaging. Am Heart J (1989) 0.85
The circle of Willis in healthy older persons. J Cardiovasc Surg (Torino) (2002) 0.84
A major involvement of the cardiovascular system in patients affected by Marfan syndrome: novel mutations in fibrillin 1 gene. J Mol Cell Cardiol (1997) 0.84
Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin. Thromb Haemost (1998) 0.84
Differences in some circadian patterns of cardiac arrhythmia, myocardial infarctions and other adverse vascular events. Chronobiologia (1994) 0.84
Renal adaptation to stress: a possible role of endothelin release and prostaglandin modulation in the human subject. J Lab Clin Med (1997) 0.84
Age related changes of platelet prostacyclin receptors in humans. Eur J Clin Invest (1985) 0.83
Acute reduction of TxA2 platelet binding sites after in vivo administration of a TxA2 receptor inhibitor. Br J Clin Pharmacol (1991) 0.83
Relationship between physical activity and cardiovascular disease. Selected historical highlights. J Sports Med Phys Fitness (2007) 0.83
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. Thromb Haemost (1999) 0.83
ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest (2003) 0.83
TxA2 production by human arteries and veins. Prostaglandins (1983) 0.83
Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension (1998) 0.83
Excessive vasoconstriction after stress by the aging kidney: inadequate prostaglandin modulation of increased endothelin activity. J Lab Clin Med (1998) 0.83
Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol (1998) 0.82
[I/D polymorphism of the ACE gene and A1166C of the AT1R gene as risk factors for restenosis after coronary angioplasty]. Minerva Cardioangiol (1999) 0.82
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1996) 0.82
Characterization of Khorasan wheat (Kamut) and impact of a replacement diet on cardiovascular risk factors: cross-over dietary intervention study. Eur J Clin Nutr (2013) 0.82
Age-related and vasomotor stimuli-induced changes in renal vascular resistance detected by Doppler ultrasound. Am J Hypertens (1996) 0.82
Videolaparoscopic cholecystectomy induces a hemostasis activation of lower grade than does open surgery. Surg Endosc (2000) 0.82
Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia. Angiology (1987) 0.82
Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. Nutr Metab Cardiovasc Dis (2012) 0.82
Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. Int J Cardiol (2009) 0.82